Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-09-06 Sale |
2023-09-08 5:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
58,765 | $8.8053 | $517,442 | 10,211,374 (Indirect Direct) |
View |
2023-09-05 Sale |
2023-09-07 7:02 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $8.7942 | $78,136 | 7,451,845 (Direct) |
View |
2023-08-24 Sale |
2023-08-28 6:04 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $8.6561 | $25,968 | 1,695,914 (Direct) |
View |
2023-08-22 Sale |
2023-08-24 5:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $8.9118 | $79,181 | 7,460,730 (Direct) |
View |
2023-08-15 Sale |
2023-08-17 6:39 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $9.25 | $166,500 | 890,213 (Direct) |
View |
2023-08-15 Sale |
2023-08-17 6:35 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
50,000 | $9.0862 | $454,310 | 4,969,088 (Direct) |
View |
2023-08-08 Sale |
2023-08-10 5:33 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
17,770 | $11.16 | $198,283 | 7,469,615 (Direct) |
View |
2023-08-02 Sale |
2023-08-04 5:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
65,015 | $13.04 | $847,712 | 10,297,052 (Indirect Direct) |
View |
2023-07-27 Sale |
2023-07-28 5:50 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $13.62 | $108,994 | 1,704,292 (Direct) |
View |
2023-07-25 Sale |
2023-07-27 6:31 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
40,000 | $14.36 | $574,200 | 1,401,285 (Direct) |
View |
2023-07-25 Sale |
2023-07-27 6:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
18,719 | $14.61 | $273,464 | 7,487,385 (Direct) |
View |
2023-07-18 Sale |
2023-07-19 7:07 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
50,000 | $14.58 | $729,150 | 4,246,494 (Direct) |
View |
2023-07-17 Sale |
2023-07-19 7:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
60,000 | $12.73 | $763,800 | 1,491,285 (Direct) |
View |
2023-07-12 Sale |
2023-07-14 6:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
56,818 | $12.54 | $712,242 | 10,372,067 (Indirect Direct) |
View |
2023-07-12 Sale |
2023-07-14 6:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
117,000 | $12.07 | $1,412,414 | 54,847 (Direct) |
View |
2023-07-11 Sale |
2023-07-13 4:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $6.8873 | $61,194 | 7,520,104 (Direct) |
View |
2023-06-29 Sale |
2023-07-03 3:21 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $7.49 | $22,470 | 1,712,292 (Direct) |
View |
2023-06-27 Sale |
2023-06-29 5:57 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $7.3876 | $65,639 | 7,528,989 (Direct) |
View |
2023-06-15 Sale |
2023-06-20 6:56 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
60,000 | $9.54 | $572,400 | 1,611,285 (Direct) |
View |
2023-06-13 Sale |
2023-06-15 7:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
15,485 | $9.9778 | $154,506 | 7,525,262 (Direct) |
View |
2023-06-13 Sale |
2023-06-15 7:28 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
50,000 | $10 | $500,145 | 4,371,494 (Direct) |
View |
2023-06-07 Sale |
2023-06-09 5:12 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
56,436 | $9.0511 | $510,808 | 10,438,885 (Indirect Direct) |
View |
2023-06-01 Sale |
2023-06-05 6:29 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
42,865 | $8.7259 | $374,034 | 143,954 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-09-06 Exercise |
2023-09-08 5:01 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,211,374 (Direct) |
View |
2023-09-06 Exercise |
2023-09-08 5:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,211,374 (Direct) |
View |
2023-09-06 Conversion |
2023-09-08 5:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,211,374 (Indirect) |
View |
2023-08-24 Exercise |
2023-08-28 6:04 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $0 | 1,695,914 (Direct) |
View |
2023-08-24 Exercise |
2023-08-28 6:04 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $1.06 | 1,695,914 (Direct) |
View |
2023-08-15 Tax Withholding |
2023-08-17 6:41 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
5,378 | $9.18 | 418,782 (Direct) |
View |
2023-08-15 Tax Withholding |
2023-08-17 6:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
16,913 | $9.19 | 873,806 (Direct) |
View |
2023-08-15 Exercise |
2023-08-17 6:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $2.22 | 890,213 (Direct) |
View |
2023-08-15 Exercise |
2023-08-17 6:39 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
18,000 | $0 | 890,213 (Direct) |
View |
2023-08-15 Tax Withholding |
2023-08-17 6:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
3,603 | $9.19 | 890,213 (Direct) |
View |
2023-08-15 Exercise |
2023-08-17 6:35 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $2.22 | 4,969,088 (Direct) |
View |
2023-08-15 Exercise |
2023-08-17 6:35 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $0 | 4,969,088 (Direct) |
View |
2023-08-15 Tax Withholding |
2023-08-17 6:35 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
4,727 | $9.19 | 4,969,088 (Direct) |
View |
2023-08-09 Gift |
2023-08-11 4:59 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,326,976 (Direct) |
View |
2023-08-09 Conversion |
2023-08-11 4:59 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,326,976 (Direct) |
View |
2023-08-02 Exercise |
2023-08-04 5:51 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,924 | $0 | 10,297,052 (Direct) |
View |
2023-08-02 Exercise |
2023-08-04 5:51 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
8,674 | $11.4 | 10,297,052 (Direct) |
View |
2023-08-02 Exercise |
2023-08-04 5:51 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,297,052 (Direct) |
View |
2023-07-29 Exercise |
2023-07-28 5:50 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $0 | 1,704,292 (Direct) |
View |
2023-07-27 Exercise |
2023-07-28 5:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $1.06 | 1,704,292 (Direct) |
View |
2023-07-25 Exercise |
2023-07-27 6:31 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
40,000 | $2.22 | 1,401,285 (Direct) |
View |
2023-07-25 Exercise |
2023-07-27 6:31 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
40,000 | $0 | 1,401,285 (Direct) |
View |
2023-06-29 Gift |
2023-07-27 6:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
14,000 | $0 | 7,487,385 (Direct) |
View |
2023-07-20 Gift |
2023-07-21 5:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,362,067 (Direct) |
View |
2023-07-20 Conversion |
2023-07-21 5:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,362,067 (Direct) |
View |
2023-07-18 Exercise |
2023-07-19 7:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $2.22 | 4,246,494 (Direct) |
View |
2023-07-18 Exercise |
2023-07-19 7:07 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $0 | 4,246,494 (Direct) |
View |
2023-07-17 Exercise |
2023-07-19 7:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
60,000 | $2.22 | 1,491,285 (Direct) |
View |
2023-07-17 Exercise |
2023-07-19 7:01 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
60,000 | $0 | 1,491,285 (Direct) |
View |
2023-07-12 Exercise |
2023-07-14 6:52 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,372,067 (Direct) |
View |
2023-07-12 Exercise |
2023-07-14 6:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,372,067 (Direct) |
View |
2023-07-12 Conversion |
2023-07-14 6:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,372,067 (Indirect) |
View |
2023-07-03 Option Award |
2023-07-06 6:10 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,609 | $0 | 3,824,509 (Direct) |
View |
2023-07-03 Option Award |
2023-07-06 6:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
1,863 | $0 | 72,044 (Direct) |
View |
2023-07-03 Option Award |
2023-07-06 6:06 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
2,541 | $0 | 53,558 (Direct) |
View |
2023-07-03 Option Award |
2023-07-06 6:04 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
1,440 | $0 | 13,628,602 (Direct) |
View |
2023-06-29 Exercise |
2023-07-03 3:21 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $0 | 1,712,292 (Direct) |
View |
2023-06-29 Exercise |
2023-07-03 3:21 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,000 | $1.06 | 1,712,292 (Direct) |
View |
2023-06-16 Option Award |
2023-06-21 5:24 pm |
2024-06-16 2033-06-16 |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
37,836 | $0 | 7,611,888 (Direct) |
View |
2023-06-16 Option Award |
2023-06-21 5:23 pm |
2024-06-16 2033-06-16 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
37,836 | $0 | 3,912,361 (Direct) |
View |
2023-06-16 Option Award |
2023-06-21 5:21 pm |
2024-06-16 2033-06-16 |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
37,836 | $0 | 131,695 (Direct) |
View |
2023-06-16 Option Award |
2023-06-21 5:20 pm |
2024-06-16 2033-06-16 |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
37,836 | $0 | 637,633 (Direct) |
View |
2023-06-16 Option Award |
2023-06-21 5:19 pm |
2024-06-16 2033-06-16 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
37,836 | $0 | 650,549 (Direct) |
View |
2023-06-16 Option Award |
2023-06-21 5:17 pm |
2024-06-16 2033-06-16 |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
37,836 | $0 | 650,031 (Direct) |
View |
2023-06-15 Exercise |
2023-06-20 6:56 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
60,000 | $2.22 | 1,611,285 (Direct) |
View |
2023-06-15 Exercise |
2023-06-20 6:56 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
60,000 | $0 | 1,611,285 (Direct) |
View |
2023-06-15 Gift |
2023-06-16 5:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,428,885 (Direct) |
View |
2023-06-15 Conversion |
2023-06-16 5:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,428,885 (Direct) |
View |
2023-06-13 Exercise |
2023-06-15 7:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $2.22 | 4,371,494 (Direct) |
View |
2023-06-13 Exercise |
2023-06-15 7:28 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $0 | 4,371,494 (Direct) |
View |
2023-06-07 Exercise |
2023-06-09 5:12 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,438,885 (Direct) |
View |
2023-06-07 Exercise |
2023-06-09 5:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,438,885 (Direct) |
View |
2023-06-01 Option Award |
2023-06-07 7:36 pm |
N/A 2033-06-01 |
RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer |
572,139 | $0 | 572,139 (Direct) |
View |
Ownership |
2023-06-07 7:35 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |